Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
allergan
2
×
biotech
2
×
boston blog main
boston top stories
clinical trials
life sciences
national blog main
abbvie
alkermes
boston
buprenorphine
cariprazine
crispr
cynthia collins
drugs
editas medicine
eli lilly
europe
europe blog main
europe top stories
fda
felipe jain
gene editing
jess fiedorowicz
jessica jeffrey
karim calis
katrine bosley
leber congenital amaurosis
lumateperone
m health fairview
marc goodman
massachusetts general hospital
national institutes of health (nih)
national top stories
olanzapine
opioid
ottawa hospital
samidorphan
steven meisel
svb leerink
What
medicine
2
×
alkermes
allergan
antipsychotic
benefits
blessing
bosley
caveats
ceo
check
clinical
commonly
crispr
cusp
depart
designed
drug
editas
editing
effect
experimental
favor
fda
gain
gene
humans
katrine
million
offer
panel
partner
prescribed
psyche
regulatory
test
therapy
treatment
trial
vote
weighs
Language
unset
Current search:
allergan
×
biotech
×
medicine
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
